Companies, which support ECNC
About GE Healthcare - GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform and treat disease, so their patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases, and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $15 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 43,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
Our Vision - At GE Healthcare, we strive to see life more clearly. We help predict, diagnose, inform and treat so that every individual can live life to the fullest.
Covidien and Nuclear Medicine Covidien
has a long history in the field of Nuclear Medicine in general and Nuclear Cardiology in particular. As one of the first suppliers of Thallium 201, our continuing commitment to diagnostic cardiology can be seen in our launch of Technetium Tc 99m Sestamibi along with other products like I123-mIBG. With our optimal geographical coverage, unique in-house Molybdenum-99 processing and broad portfolio of conventional products as well as specialties, we deliver quality products every day to meet the needs of our customers and the patients they serve.
Covidien’s Pharmaceuticals business produces a full line of contrast media and delivery systems, radiopharmaceuticals and urology imaging systems for the diagnosis and treatment of disease. The business also manufactures and distributes a range of products including specialty branded and generic pharmaceuticals, as well as active ingredients used in manufacturing of prescription drugs and over-the-counter products. The mission of Covidien’s Pharmaceuticals business is to make diagnostics and medicines better and safer for you and your family.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies.
DDD-Diagnostic was established in 1987 as a company that develops, manufactures and markets gamma cameras for nuclear medicine. The cameras are used for scanning heart, kidney and cancer patients. The cameras are among other places used by privately practicing cardiologists and hospitals in connection with the diagnosis of cardiopulmonary diseases.
The gamma cameras are primarily marketed in the USA through major companies that distribute the products under their own brand.
Since it’s foundation, DDD-Diagnostic has brought innovation to the field of nuclear medicine, with the development of the first and second generation of dedicated cardiac camera for private cardiology practices as well as the world’s first dedicated gamma camera for brain scans. Furthermore, DDD-Diagnostic has been involved in the development of a number of the most widely sold general purpose gamma cameras for hospital use.
DDD-Diagnostic is today the world’s leading manufacturer of dedicated nuclear medical heart cameras with a market share of more than 50%.
By integrating molecular imaging technologies into the clinical workflow, Siemens provides solutions that help physicians to diagnose disease earlier - and thus help save lives and reduce costs. From outstanding preclinical systems to award winning clinical imagers to comprehensive solutions for biomarkers, we are helping transform health care along the entire care path. With cutting-edge innovations, Siemens continues to develop new products, IT solutions, and radiopharmaceuticals that will further the technological possibilities of molecular imaging and pave the road toward personalized medicine.
Our innovative solutions in cardiology include SPECT, SPECT*CT and PET*CT systems, which are fully integrated with syngo® for optimized cardiology disease management and connectivity. And with MI LifeNet, you can improve the efficiency of your practice with a comprehensive array of educational, marketing and practice management resources.
At Siemens Molecular Imaging, innovation is in our genes.